Company & Sponsor Intelligence
Institute of Child Health
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials3
Recruiting0
Completed2
Countries1
Therapeutic footprint
epilepsyout_of_scope
Indexed studies
NCT00415727Prevention Of Morbidity In Sickle Cell Disease Pilot Phase
out_of_scope · United KingdomPHASE2
out_of_scope · United KingdomPHASE2
NCT00564915RCT of the Efficacy of the Ketogenic Diet in the Treatment of Epilepsy
epilepsy · United KingdomPHASE4
epilepsy · United KingdomPHASE4
NCT03948620Macrolide in Pregnancy and Adverse Child Outcomes
out_of_scope · COMPLETED
out_of_scope · COMPLETED
Intelligence layer updated: 2026-10-11 23:31:09.606883+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →